# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA3220222 | 7 | INH | 0 | ALA3222884 | Not Active | % | Homo sapiens | ||||
2. | Bortezomib (PS-341) | 15 | INH | 0 | ALA3222885 | Active | % | Homo sapiens | ||||
3. | ALA3220221 | 1 | INH | 0 | ALA3222884 | Active | % | Homo sapiens | ||||
4. | ALA3220222 | 7 | INH | 0 | ALA3222883 | Dose-dependent effect | % | Homo sapiens | ||||
5. | ALA3220221 | 1 | INH | 0 | ALA3222883 | Dose-dependent effect | % | Homo sapiens | ||||
6. | Bortezomib (PS-341) | 15 | IC50 | = | 2.56 | nM | ALA3222879 | 8.59 | nM | Homo sapiens | ||
7. | ALA3220222 | 7 | IC50 | = | 225 | uM | ALA3222879 | nM | Homo sapiens | |||
8. | ALA3220221 | 1 | IC50 | = | 108 | uM | ALA3222879 | nM | Homo sapiens | |||
9. | ALA3291291 | 4 | IC50 | = | 5.7 | uM | ALA3295791 | 5.24 | nM | Homo sapiens | ||
10. | ALA3291290 | 3 | IC50 | = | 2.3 | uM | ALA3295791 | 5.64 | nM | Homo sapiens | ||
11. | ALA3237861 | 2 | IC50 | = | 29 | nM | ALA3295791 | 7.54 | nM | Homo sapiens | ||
12. | ALA3237860 | 1 | IC50 | = | 5.7 | nM | ALA3295791 | 8.24 | nM | Homo sapiens | ||
13. | ALA491636 | 1 | IC50 | = | 1440 | nM | ALA3295791 | 5.84 | nM | Homo sapiens | ||
14. | ALA491636 | 1 | IC50 | = | 1400 | nM | ALA3240083 | 5.85 | nM | Homo sapiens | ||
15. | ALA3237861 | 2 | IC50 | = | 29 | nM | ALA3240083 | 7.54 | nM | Homo sapiens | ||
16. | ALA3237860 | 1 | IC50 | = | 5.7 | nM | ALA3240083 | 8.24 | nM | Homo sapiens | ||
17. | Carfilzomib | 2 | INH | 0 | ALA3242188 | Active | % | Homo sapiens | ||||
18. | ALA3237863 | 4a | INH | 0 | ALA3242188 | Active | % | Homo sapiens | ||||
19. | Bortezomib (PS-341) | 15 | INH | 0 | ALA3242187 | Active | % | Homo sapiens | ||||
20. | ALA3237873 | 11a | INH | 0 | ALA3242187 | Active | % | Homo sapiens |